Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: June 2, 2005
Last updated: November 5, 2013
Last verified: February 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)